Novartis NVS obtained FDA approval for onasemnogene abeparvovec-brve, a gene replacement therapy, for children two years and ...

The FDA has approved Itvisma (onasemnogene abeparvovec-brve) to treat children two years and older, teens, and adults living with spinal muscular atrophy (SMA). It is indicated for patients with a ...

Itvisma contains the active ingredient in Zolgensma approved in 2019 for children younger than 2 years but is reformulated ...

The global solar inverter market was valued at US$12.81 billion in 2023 and is forecasted to reach US$24.40 billion by 2029, with a CAGR of 11.34% from 2024-2029. Solar inverters are crucial for ...

In light of geopolitical tensions and real purchasing power losses, precious metal prices are on the rise – and there is no ...

Investing.com -- Jefferies upgraded German solar inverter manufacturer SMA Solar to “buy” from “hold” and raised its price target to €39 from €22, citing improved profitability prospects driven by ...

At RE+ 2025, SMA America announced it will officially launch the new utility-scale Sunny Central Storage UP-S. Visitors to Booth V9713 will also get a first look at the new Sunny Highpower Storage, ...

SMA Solar is well-positioned in the Utility inverter market, especially in Germany and the US, which are growing markets. The stock has been severely affected by a sharp decline in commercial and ...

Santa Clara, CA and Kyoto, Japan, April 28, 2025 (GLOBE NEWSWIRE) -- ROHM Semiconductor today announced that SMA Solar Technology AG, a leading global specialist in photovoltaic and storage system ...

SMA America introduced two new hybrid inverters for residential solar projects with larger solar capacity. The Sunny Boy Smart Energy inverters include a 9.6 kW and an 11.5 kW model. The DC-coupled ...